Back

Effect of left atrial function on cardiovascular outcome in non-dilated left ventricular cardiomyopathy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertrophic and other cardiomyopathies: miscellaneous findings Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jeongmin Kang

Ewha Womans University, Seoul (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Sex-based differences in anatomical and hemodynamic parameters and outcomes in patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation
Doctor A. Damlin (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and burden of non-obstructive hypertrophic cardiomyopathy: a real-world survey in Italy and Spain
Miss M. Lowe (Macclesfield, GB)
Abstract Slides Video
Presentation thumbnail
Symptoms trend in patients with obstructive hypertrophic cardiomyopathy treated with disopyramide.
Doctor F. Borrelli (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: observations from a tertiary care center
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Amplicon-based long-read sequencing is useful for confirming zygosity of DSG2 variants associated with Japanese ARVC.
Doctor K. Sonoda (Suita, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic and other cardiomyopathies: miscellaneous findings

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart
thumbnail
Congress Presentation
Left atrial strain predicts adverse events in hypertrophic cardiomyopathy: preliminary results from a CMR study
thumbnail
Congress Presentation
Association of left atrial strain with long-term cardiovascular mortality in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources